WHOOP and Samuel Ross MBE Announce Multiyear, Global Creative Partnership, Introducing a New Era in Performance Fashion
The WHOOP x SR_A collaboration ushers in a new frontier of performance accessories, apparel, and design-driven technology
WHOOP, the human performance company, announces a landmark creative partnership with acclaimed designer Samuel Ross MBE, who joins as Global Creative Director, WHOOP x SR_A to lead a multiyear collaboration between the two brands titled PROJECT TERRAIN. The collaboration signals the ongoing evolution of WHOOP from a pioneering wearable technology company into a brand shaping not just the future of personal health but also its intersection with performance fashion and cultural design.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260115643104/en/

WHOOP and Samuel Ross MBE Announce Multiyear, Global Creative Partnership, Introducing a New Era in Performance Fashion
As the first performance design collaboration for WHOOP, the partnership represents a new chapter for the brand. Under Ross’ direction, PROJECT TERRAIN will deliver a bespoke capsule collection including limited-edition, customized WHOOP bands. The range will also include new apparel pieces within the WHOOP Body collection, technical garments that enable wearing WHOOP beyond the wrist, arriving in limited edition drops this year and into 2028.
Under the moniker of his award winning design studio, SR_A (previously notably founding A-Cold-Wall*), Ross’ work spans forty footwear models with Nike and Converse, Oakley across three collections, five years of product partnerships with LVMH via Hublot watch designs and experimental fragrances with Acqua di Parma, to the first external design role within Apple Group as Principal Design Consultant at Beats. He has consistently reimagined how culture, material science, and form influence one another. His transition into performance innovation with WHOOP represents a natural progression for an industrial designer whose work centers on precision, human movement, and the evolution of contemporary aesthetics. Ross has worn WHOOP for five years, forming an immediate, authentic connection to its design, culture, and technology.
“At WHOOP, we've always believed that wearable technology needs to be invisible or it needs to be cool,” said Will Ahmed, Founder and CEO of WHOOP. “Working with Samuel Ross has been a true joy. He deeply understands wearable technology. Our members will feel something new and different when they wear this limited collection.”
Speaking of the joint venture, Johan Liden, Chief Creative Officer of WHOOP, said, “Design has always been core to how WHOOP delivers meaningful impact, and Samuel brings a level of craft and provocation that pushes that mission even further. His approach to materials, form, and function aligns perfectly with our ambition to create products that are both deeply technical and emotionally resonant. Our collaboration enables us to expand the WHOOP design language into an entirely new dimension—one that empowers members to experience performance and self-expression in ways they never have before.”
The Creative Vision Behind PROJECT TERRAIN
SR_A’s industrial and architectural ethos will define the visual and tactile identity of the upcoming WHOOP x SR_A capsule, PROJECT TERRAIN. The studio’s commitment to precision, material innovation, and functional clarity introduces a new design vocabulary for WHOOP, informed by utility, intentionality, and structural, materials-driven design approach.
Samuel Ross, Global Creative Director, WHOOP x SR_A, said, “WHOOP is shaping the future. That’s true progress, for all. It is one of the first design and technology companies of our generation, founded within our generation, by our generation, that is defining the right relationship to health, through advanced technology. I look forward to building the future with Will and the WHOOP design teams. We have a clear, sharp vision to move global design expectations forward.”
“This landmark joint venture reflects our shared vision for the future of wearable technology and the power of innovation and creativity,” said Yi Ng, Co-founder and CEO of SR_A. “As an industry first, it underscores our mutual commitment to pushing boundaries. Partnering with WHOOP enables us to elevate SR_A’s mission while creating products that connect with a global audience.”
As part of this collaboration, SR_A will join as an investor, alongside investor-partners including Niall Horan and Cristiano Ronaldo. WHOOP will also contribute to the SR_A Black British Artist Grant and host its selected recipient for an in-house design residency, enabling emerging talent to collaborate directly with WHOOP creative teams.
To view images please visit the Digital Press Kit. The first limited-edition WHOOP x SR_A capsule will be available globally in the coming months at shop.whoop.com.
About WHOOP:
WHOOP, the human performance company, empowers people to unlock their potential and live longer, healthier lives. The WHOOP membership delivers world-class wearable technology, personalized coaching, and actionable insights across recovery, sleep, training, and health.
WHOOP wearable devices, including WHOOP 5.0 and WHOOP MG, feature groundbreaking innovations such as cardiovascular health screening (including an FDA-cleared ECG), Healthspan to measure Pace of Aging and WHOOP Age, and the first-of-its-kind wearable Blood Pressure Insights.
Founded in 2012 and headquartered in Boston, WHOOP has raised more than $400 million in venture capital and ships to 56 markets worldwide. To learn more or start a one-month free trial, visit whoop.com and connect with WHOOP on Instagram, X, Facebook, LinkedIn, and YouTube.
About SR_A:
SR_A is a Global Design Studio spanning industrial design, garment design & architecture, headquartered in London, U.K. co-founded by Samuel Ross and his long-time business partner, Yi Ng.
The studio is known for its distinct, bold visual style that merges a minimalist ethos and deeply functional decisions that blur design disciplines.
The Design Studio has received numerous global accolades, from the LVMH Design prize (2019), Three British Fashion Awards (2017-2022), two EDIDA Awards (2025), the Fuori Salone Awards (2024), & the Design Miami Basel Award for best contemporary design (2024).
The Design Studio holds numerous patents within the luxury and design sector, having collaborated with multiyear global partners including LVMH group (2019-2025), Apple Group (2020-2025), Nike Group (2016-2024) and Inditex Group (2025).
SR_A designs live permanently across global museums through direct acquisition, including The Met, The V&A, & The Design Museum.
Product designs have ranged from $200 fragrances to $150k Tourbillon watches.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260115643104/en/

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Lone Star Announces Sale of SENQCIA to Noritsu Koki15.1.2026 14:30:00 CET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XI, L.P. has entered into a definitive agreement to sell SENQCIA Corporation (“SENQCIA”), a leading provider of mission-critical building products and solutions in Japan, to Noritsu Koki Co., Ltd., in a transaction that represents a total enterprise value of approximately $519 million. Headquartered in Tokyo, SENQCIA develops, designs and distributes essential structural solutions that enhance the resilience, integrity and long-term safety of buildings and infrastructure. The company’s diversified product portfolio serves a broad range of end-markets and property types that are used in many iconic landmark properties across Japan. SENQCIA’s solutions help address key structural challenges facing Japan, including increasing natural disaster risk and aging infrastructure and building stock. During Lone Star’s ownership, SENQCIA has enhanced its go-to-market strategy and reinforced its operational resilience
Altris and Draslovka Partner to Scale Europe’s First Sodium-Ion Battery Technology Supply Chain15.1.2026 14:00:00 CET | Press release
Altris, a Swedish sodium-ion battery developer, and Draslovka, a global leader in specialty chemicals, have entered a strategic partnership to build Europe’s first industrial-scale sodium-ion cathode value chain. Under the comprehensive agreement that includes a total 19.3 MEUR in-kind investment by Draslovka in Altris, the two companies will scale fully connected production of Altris’ patented sodium-ion cathode active material (CAM) at Draslovka’s facility in Kolín, Czech Republic, supplying up to 350 tonnes of CAM annually. Draslovka and Altris are partnering to convert an existing line at Draslovka’s Kolín facility for production of Altris’ sodium-ion CAM, enabling rapid time-to-market and capital-efficient scale-up. Once ramped, the line will support production of up to 350 tonnes annually – a European-controlled supply equivalent to around 175 MWh of sodium-ion cell capacity. As part of the agreement, Draslovka is making a new in‑kind 19.3 MEUR strategic investment in Altris to c
CPP Investments Increases Commitment to Canadian Market through Northleaf Capital Partners15.1.2026 14:00:00 CET | Press release
Canada Pension Plan Investment Board (CPP Investments) and Northleaf Capital Partners (Northleaf) today announced a significant expansion of their longstanding Canadian investment partnership, supporting the growth and scaling of domestic private companies. CPP Investments has committed to invest an additional C$750 million through its established Canadian mid-market program managed by Northleaf, bringing CPP Investments’ cumulative commitments to the manager to more than C$3 billion since inception. The customized mandate focuses on maximizing net returns through a diversified strategy that includes primary fund commitments to small and mid-market Canadian buyout funds, secondary investments, and direct co-investments focused on the domestic market. “There are compelling investment opportunities in the Canadian market, and our two-decade long partnership with Northleaf has proven to be an effective and scalable way to invest in homegrown businesses with patient, long-term capital,” sa
Vantage Data Centers Completes £200M Tap of Existing £600M Industry-First EMEA Data Center Asset-Backed Securitization (ABS) and Adds New £54M Class B Tranche15.1.2026 14:00:00 CET | Press release
Financing will support the company’s expansion across EMEA to keep pace with AI and cloud demand Vantage Data Centers, a leading global provider of hyperscale data center campuses, today announced it has raised an additional £254 million in securitized term notes. £200 million was raised through a tap of the existing Class A-2 Notes while £54 million was raised from the new Class B Tranche. This builds on Vantage’s debut public issuance in 2024 raising £600 million, which was the first-ever EMEA data center ABS completed in sterling. The Class A-2 Notes are rated A-, A (low) and A by Standard & Poor’s, Morningstar DBRS and Scope Ratings, respectively. The Class B Notes are rated BBB- by Standard & Poor’s and BBB by Morningstar DBRS and Scope Ratings. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260115777091/en/ Vantage’s 148MW Cardiff, Wales, campus is one of Europe’s largest hyperscale data center campuses. The new notes
QPS Selects Oracle Argus Safety Database to Enhance Pharmacovigilance in Clinical Trials15.1.2026 13:57:00 CET | Press release
QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle Argus, a premier pharmacovigilance system designed to support comprehensive safety case management for clinical trials. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260115711485/en/ Derek Grimes, EVP, Global Head of Clinical Research at QPS Holdings, LLC. The adoption of the Oracle Argus drug safety platform underscores QPS’s commitment to advancing patient safety, regulatory compliance, and operational excellence across its clients’ clinical drug development programs. Integrating this industry-standard safety platform strengthens QPS’ ability to capture, manage, and report adverse events in accordance with global regulatory requirements. “Ensuring patient safety and data integrity is at the heart of what we do when conducting clinical trials,” said Dere
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom